TATAA Biocenter Receives French Ministry Approval
News Aug 12, 2014
TATAA Biocenter, Europe´s leading provider of genomic services, has been approved by the French Ministry of Higher Education and Research (www.recherche.gouv.fr) as an organization carrying out R&D activities for the account of private companies. “This entitles our French customers tax reduction” says Dr. Mikael Kubista, founder and CEO of TATAA Biocenter, “and makes us even more competitive on the French market, where we already have the pleasure of serving some of Europe´s most innovative Life Science companies”
Giant Viruses Invent Their Own GenesNews
Three new members have been isolated and added to the Pandoravirus family. This strange family of viruses, with their giant genomes and many genes with no known equivalents, surprised scientists when they were discovered a few years ago. This new study notes that pandoraviruses appear to be factories for new genes – and therefore new functions.
Therapeutic CRISPR Could Be Cancer RiskNews
Therapeutic use of gene editing with the so-called CRISPR-Cas9 technique may inadvertently increase the risk of cancer, according to a new study. Researchers say that more studies are required in order to guarantee the safety of these ‘molecular scissors’ for gene-editing therapies.
Who Owns the Ocean? One Company Has Registered Half of All Marine Gene PatentsNews
A single corporation has registered nearly half of all existing patents associated with genes from marine organisms, according to a new study. Researchers from the University of British Columbia and the Stockholm Resilience Centre examined the patents associated with marine species and found that BASF, the world’s largest chemical manufacturer, has registered 47 per cent of the 12,998 genetic sequences from 862 marine species.